Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Milestone Pharmaceuticals stock | $5.555

Learn how to easily invest in Milestone Pharmaceuticals stock.

Milestone Pharmaceuticals Inc is a biotechnology business based in the US. Milestone Pharmaceuticals shares (MIST) are listed on the NASDAQ and all prices are listed in US Dollars. Milestone Pharmaceuticals employs 28 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Milestone Pharmaceuticals

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – MIST – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Milestone Pharmaceuticals stock price (NASDAQ: MIST)

Use our graph to track the performance of MIST stocks over time.

Milestone Pharmaceuticals shares at a glance

Information last updated 2021-10-23.
Latest market close$5.56
52-week range$5.09 - $9.03
50-day moving average $5.71
200-day moving average $5.66
Wall St. target price$13.60
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-1.09

Buy Milestone Pharmaceuticals shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
$20 per year
Financial advice powered by relationships, not commissions.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Milestone Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Milestone Pharmaceuticals price performance over time

Historical closes compared with the close of $5.555 from 2021-10-22

1 week (2021-10-19) -3.20%
1 month (2021-09-24) -0.80%
3 months (2021-07-26) 0.63%
6 months (2021-04-26) -6.01%
1 year (2020-10-26) -0.27%
2 years (2019-10-25) -72.90%
3 years (2018-10-22) N/A
5 years (2016-10-22) N/A

Milestone Pharmaceuticals financials

Revenue TTM $15 million
Gross profit TTM $0
Return on assets TTM -17.14%
Return on equity TTM -28.46%
Profit margin -215.93%
Book value $4.68
Market capitalisation $165.8 million

TTM: trailing 12 months

Shorting Milestone Pharmaceuticals shares

There are currently 182,726 Milestone Pharmaceuticals shares held short by investors – that's known as Milestone Pharmaceuticals's "short interest". This figure is 1.8% down from 186,022 last month.

There are a few different ways that this level of interest in shorting Milestone Pharmaceuticals shares can be evaluated.

Milestone Pharmaceuticals's "short interest ratio" (SIR)

Milestone Pharmaceuticals's "short interest ratio" (SIR) is the quantity of Milestone Pharmaceuticals shares currently shorted divided by the average quantity of Milestone Pharmaceuticals shares traded daily (recently around 32057.192982456). Milestone Pharmaceuticals's SIR currently stands at 5.7. In other words for every 100,000 Milestone Pharmaceuticals shares traded daily on the market, roughly 5700 shares are currently held short.

However Milestone Pharmaceuticals's short interest can also be evaluated against the total number of Milestone Pharmaceuticals shares, or, against the total number of tradable Milestone Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Milestone Pharmaceuticals's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Milestone Pharmaceuticals shares in existence, roughly 10 shares are currently held short) or 0.0073% of the tradable shares (for every 100,000 tradable Milestone Pharmaceuticals shares, roughly 7 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Milestone Pharmaceuticals.

Find out more about how you can short Milestone Pharmaceuticals stock.

Milestone Pharmaceuticals share dividends

We're not expecting Milestone Pharmaceuticals to pay a dividend over the next 12 months.

Milestone Pharmaceuticals share price volatility

Over the last 12 months, Milestone Pharmaceuticals's shares have ranged in value from as little as $5.09 up to $9.034. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Milestone Pharmaceuticals's is 3.7525. This would suggest that Milestone Pharmaceuticals's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Milestone Pharmaceuticals overview

Milestone Pharmaceuticals Inc. , a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. It is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada, as well as in the Phase II clinical trial for the treatment of atrial fibrillation and rapid ventricular rate, and other cardiovascular indications. Milestone Pharmaceuticals Inc. has a license and collaboration agreement with Ji Xing Pharmaceuticals to develop and commercialize etripamil in patients with paroxysmal supraventricular tachycardia and additional cardiovascular conditions in Greater China. The company was incorporated in 2003 and is headquartered in Montréal, Canada. .

Frequently asked questions

What percentage of Milestone Pharmaceuticals is owned by insiders or institutions?
Currently 9.654% of Milestone Pharmaceuticals shares are held by insiders and 75.052% by institutions.
How many people work for Milestone Pharmaceuticals?
Latest data suggests 28 work at Milestone Pharmaceuticals.
When does the fiscal year end for Milestone Pharmaceuticals?
Milestone Pharmaceuticals's fiscal year ends in December.
Where is Milestone Pharmaceuticals based?
Milestone Pharmaceuticals's address is: 1111 Dr. Frederik-Philips Boulevard, Montreal, QC, Canada, H4M 2X6
What is Milestone Pharmaceuticals's ISIN number?
Milestone Pharmaceuticals's international securities identification number is: CA59935V1076
What is Milestone Pharmaceuticals's CUSIP number?
Milestone Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 59935V107

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site